RxDoctor Payments DataLook up a doctor →

Gustavo Cumbo Nacheli

Pulmonary Disease · Grand Rapids, MINPI 1013124312

Payments from drug & device makers

$832,653in general payments, 2019–2025

Across 656 payments — averaging $1269.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$422K
  • AstraZeneca$158K
  • Medical Device Business Services, Inc.$102K
  • Ethicon Endo-surgery Inc.$72K
  • GE HealthCare$56K
  • Siemens Medical Solutions USA, Inc.$10K
  • plus $12K from 15 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$832,653 in reported general payments places this provider in the 95th percentile of 463 pulmonary disease providers in Michigan.

See all pulmonary disease providers in Michigan

Medicare billing

Part B allowed, 2024
$45,753
Medicare patients
151
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →